2,0
2 lug 2020
Ex dipendente, più di 10 anni
South San Francisco, CA
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Father of BioOncology. Created targeted oncology and hematology products that changed the course of the disease.
Svantaggi
Will never be DNA again. Massive layoffs of long term highly skilled employees over the past six years (60+%). The departure of early and late-stage researchers has impacted future opportunities. They "don't need people managers." Little to no support from HR for retaliation and bad managers. No exit interviews. No action is taken to protect employees—multiple civil suits.